Tag: Lillys

Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.

The Food and Drug Administration (FDA) recently approved Eli Lilly's obesity drug Zepbound, also known as tirzepatide, as

Lilly’s Zepbound price cut could help customers — and boost profits

Overall, while Lilly’s move to offer discounted vials of Zepbound may seem like a positive step towards increasing